those under 50 and over 80 have the lowest relative survival rates. Because those under 50 aren't usually tested for prostate cancer, it may be less likely to be diagnosed in younger people until it reaches the later stages.
While the 5-year survival rate for local and regional prostate cancer is nearly 100%, it decreases dramatically for advanced tumours. Accessibility to health care is an important factor for cancer prognosis. The U.S. Military Health System (MHS) provides universal health care to its beneficiaries...
As prostate cancer progresses and spreads, doctors often use staging and grading systems to better treat the condition. Learn more about the stages and grades of prostate cancer at WebMD.
Prostate cancer is one of the most common forms of cancer and the third leading cause of cancer death in North America. As an integrated part of computer-aided detection (CAD) tools, diffusion-weighted magnetic resonance imaging (DWI) has been intensively studied for accurate detection of prosta...
STAGE IV PROSTATE CANCER: THE EFFECT OF TNM STAGING AND AGE OF DIAGNOSIS ON SURVIVALpriapismsubarachnoid hemorrhagetreatmentischemiccomplicationsphenylephrineblood pressuresickle cell diseaseThe SLIT2 receptor ROBO2 plays a key role in the formation of the ureteric bud, and its inactivation in mice leads...
Prostate cancer stages: Stage 1 – the cancer is in only half of one side of the prostate or less Stage 2 – the cancer is in more than half of one side of the prostate Stage 3 – the cancer has broken through the covering of the prostate gland and may have spread into the tubes ...
Because most cases of prostate cancer advance very slowly, if at all, the 10-year survival rate for screen-detected, localized prostate cancer is very high. In a recent major trial that enrolled more than 1500 men randomized to receive either active treatment or active surveillance, the 10-...
Regucalcin expression was compared in 131 primary tumor tissues and 19 metastatic tumor tissues in prostate cancer patients. Regucalcin expression in the metastatic tumor was found to be reduced as compared with that in primary tumor. The progression-free survival rate was prolonged in patients with ...
Prostate cancer (PCa) is the second most frequent type of cancer found in men worldwide and the fifth leading cause of death by cancer. In 2018, there were 1,276,106 new cases and 358,989 deaths due to PCa1. If detected in its early stages, the survival rates of PCa are high due...
WebMD's slideshow covers prostate cancer: who's at risk, symptoms, tests, staging, treatments, survival, and foods that may help lower your risk for prostate cancer.